New Vaccine Findings Post Tough Questions for Parents of Young Children

March 10, 2022

(New York Times) – In early February, federal regulators announced that they would evaluate Pfizer-BioNTech’s coronavirus vaccine for the youngest children — only to scrap that plan 10 days later, citing doubts about the vaccine’s effectiveness in that age group. Soon after, scientists reported that the vaccine was only weakly protective against infection with the Omicron variant among children aged 5 to 11 and that it appeared to offer little defense against moderate Covid illness among adolescents aged 12 to 17. On Monday, citing these data, Florida’s surgeon general declared that healthy children need not be immunized, advice that Jen Psaki, the White House press secretary, called “deeply disturbing.” (Read More)